Tolerance and efficacy of BRAF plus MEK inhibition in patients with melanoma who have received PD-1 based therapy.
暂无分享,去创建一个
R. Sullivan | Douglas B. Johnson | A. Shoushtari | A. Menzies | Angelica Bialczak | Daniel Y Wang | M. Mooradian | Kelly T Abbate | Karim R. Saab | J. Chon | C. Xia